GATE 301
Alternative Names: GATE-301Latest Information Update: 13 Oct 2022
At a glance
- Originator Gate Neurosciences
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurodegenerative disorders